Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesity.
BACKGROUND
As endometrial cancer (EC) prevalence increases with obesity, we aimed to determine whether EC characteristics depend upon obesity type: 'standard' (SO) or 'metabolically healthy obesity' (MHO).


PATIENTS & METHODS
258 EC patients were included. Data on anthropometry, blood hormones, lipids and glucose, and tumor features were collected.


RESULTS
EC clinicopathologic characteristics and clinical stage correlate differently with BMI and obesity type. BMI is related inversely with tumor grade while SO patients are characterized by a more advanced clinical stage than those with MHO. Besides typical insulin resistance signs, EC patients with SO often display a higher serum leptin/adiponectin ratio compared with MHO patients. Historical data suggest a gradual increase in EC patient height and weight, and a decrease in MHO prevalence.


CONCLUSION
It is currently unknown whether the latter observation reflects the evolution of EC, or obesity alongside the current epidemic. Regardless, the reduced MHO prevalence demonstrates the need for more intensive preventive measures aimed at obesity and obesity-associated conditions, including different EC subtypes.
['Berstein|Lev M|LM|', 'Poroshina|Tatyana E|TE|', 'Turkevich|Elena A|EA|', 'Vasilyev|Dmitry A|DA|', 'Baltrukova|Alexandra N|AN|', 'Kovalenko|Irina M|IM|', 'Berlev|Igor V|IV|']
endometrial cancer metabolically healthy obese obesity types tumor features and subtypes